Net profit after tax predicted to be in range $21M - $22M, an increase of between 13% - 18% from last year.
Growth is slowing a bit but still well above my RRR. Interest rates looking like they're not going up any time soon, and this is a good business in a well protected sector.
NPAT (A$M)
FY10 8.9
FY11 10.1 +13%
FY12 12.7 +26%
FY13 15.6 +23%
FY14 18.7 +20%
FY15 21 ... 22 (est.) +13% ... +18%
- Forums
- ASX - By Stock
- CLH
- Ann: Investor Presentation
Ann: Investor Presentation, page-2
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CLH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online